These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 26469234

  • 1. Intravitreal Lower-Dose (20 µg) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds.
    Tuncer S, Balcı Ö, Tanyıldız B, Kebudi R, Shields CL.
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):942-8. PubMed ID: 26469234
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA.
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F, Shields CL.
    Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940
    [Abstract] [Full Text] [Related]

  • 4. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL, Douglass AM, Beggache M, Say EA, Shields JA.
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M.
    Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
    [Abstract] [Full Text] [Related]

  • 6. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R.
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [Abstract] [Full Text] [Related]

  • 7. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
    Francis JH, Abramson DH, Gaillard MC, Marr BP, Beck-Popovic M, Munier FL.
    Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
    [Abstract] [Full Text] [Related]

  • 8. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW.
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [Abstract] [Full Text] [Related]

  • 9. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH, Han JW, Hahn SM, Lyu CJ, Kim DJ, Lee SC.
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H, Koç İ, Varan A, Akyüz C.
    Eur J Ophthalmol; 2017 Jun 26; 27(4):423-427. PubMed ID: 28106239
    [Abstract] [Full Text] [Related]

  • 11. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA.
    Arch Ophthalmol; 2011 Nov 26; 129(11):1399-406. PubMed ID: 21670328
    [Abstract] [Full Text] [Related]

  • 12. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
    Chao A, Kao LY, Liu L, Wang NK.
    BMC Ophthalmol; 2016 Mar 15; 16():27. PubMed ID: 26975871
    [Abstract] [Full Text] [Related]

  • 13. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH, Schaiquevich P, Buitrago E, Del Sole MJ, Zapata G, Croxatto JO, Marr BP, Brodie SE, Berra A, Chantada GL, Abramson DH.
    Ophthalmology; 2014 Sep 15; 121(9):1810-7. PubMed ID: 24819859
    [Abstract] [Full Text] [Related]

  • 14. Pathological findings in enucleated eyes after intravitreal melphalan injection.
    Ghassemi F, Amoli FA.
    Int Ophthalmol; 2014 Jun 15; 34(3):533-40. PubMed ID: 24043335
    [Abstract] [Full Text] [Related]

  • 15. Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.
    Francis JH, Marr BP, Brodie SE, Gobin YP, Abramson DH.
    JAMA Ophthalmol; 2014 Aug 15; 132(8):1024-5. PubMed ID: 25124953
    [No Abstract] [Full Text] [Related]

  • 16. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
    Sun YB, Hui P, Punyara K, Bi MC, Li SH, Teng SY, Song E.
    Chin Med J (Engl); 2013 Aug 15; 126(8):1587. PubMed ID: 23595400
    [No Abstract] [Full Text] [Related]

  • 17. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
    Bogan CM, Pierce JM, Doss SD, Tao YK, Chen SC, Boyd KL, Liao A, Hsieh T, Abramson DH, Francis JH, Friedman DL, Richmond A, Daniels AB.
    Exp Eye Res; 2021 Mar 15; 204():108439. PubMed ID: 33444583
    [Abstract] [Full Text] [Related]

  • 18. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL, Say EA, Pointdujour-Lim R, Cao C, Jabbour PM, Shields JA.
    J Fr Ophtalmol; 2015 Jun 15; 38(6):542-9. PubMed ID: 25982423
    [Abstract] [Full Text] [Related]

  • 19. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track.
    Munier FL, Soliman S, Moulin AP, Gaillard MC, Balmer A, Beck-Popovic M.
    Br J Ophthalmol; 2012 Aug 15; 96(8):1084-7. PubMed ID: 22368262
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal injection of melphalan for intraocular retinoblastoma.
    Suzuki S, Aihara Y, Fujiwara M, Sano S, Kaneko A.
    Jpn J Ophthalmol; 2015 May 15; 59(3):164-72. PubMed ID: 25808017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.